Assertio Holdings (ASRT) Capital Expenditures (2019 - 2023)
Assertio Holdings' (ASRT) quarterly Capital Expenditures came in at $348000.0 in Q4 2023, up 27.01% year-on-year from $274000.0 in Q4 2022, and up 240.32% quarter-over-quarter from -$248000.0 in Q3 2023.
Assertio Holdings (ASRT) Capital Expenditures (2019 - 2023) Analysis & Trends
Assertio Holdings has disclosed Capital Expenditures across 5 years of filings, most recently posting $348000.0 for Q4 2023.
- Capital Expenditures for Q4 2023 came in at $348000.0, up 27.01% year-over-year; the trailing twelve-month figure through Sep 2024 was $348000.0 (down 37.18% YoY), and the FY2023 annual result was $628000.0, up 129.2% from the prior year.
- Capital Expenditures came in at $348000.0 for Q4 2023 at Assertio Holdings, up from -$248000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $905000.0 in Q3 2019 to a low of -$248000.0 in Q3 2023.
- The 5-year median for Capital Expenditures is $79000.0 (2021), against an average of $182500.0.
- Across the five-year window, Capital Expenditures tumbled 99.89% in 2020 and surged 416.98% in 2022, its largest moves.
- Assertio Holdings' Capital Expenditures stood at -$45000.0 in 2019, then jumped by 102.22% to $1000.0 in 2020, then soared by 5200.0% to $53000.0 in 2021, then soared by 416.98% to $274000.0 in 2022, then rose by 27.01% to $348000.0 in 2023.
- The last three Capital Expenditures figures came in at $348000.0 (Q4 2023), -$248000.0 (Q3 2023), and $423000.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 8.83 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.04 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 348,000.00 |
| Dec 31, 2023 | 348,000.00 |
| Sep 30, 2023 | -248,000.00 |
| Sep 30, 2023 | -248,000.00 |
| Jun 30, 2023 | 423,000.00 |
| Jun 30, 2023 | 423,000.00 |
| Mar 31, 2023 | 105,000.00 |
| Mar 31, 2023 | 105,000.00 |
| Dec 31, 2022 | 274,000.00 |
| Dec 31, 2022 | 274,000.00 |
| Dec 31, 2021 | 53,000.00 |
| Dec 31, 2021 | 53,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 9,000.00 |
| Mar 31, 2020 | 9,000.00 |
| Dec 31, 2019 | -45,000.00 |
| Dec 31, 2019 | -45,000.00 |
| Sep 30, 2019 | 905,000.00 |
| Sep 30, 2019 | 905,000.00 |